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Center for Acute Disease Epidemiology (CADE) 
Iowa Department of Public Health (IDPH) 
 
Items for this week’s EPI Update include: 
• 1914 Typhoid Fever outbreak in Adel, Iowa 
• Updated sexually transmitted disease treatment guidelines 
• Middle East Respiratory Syndrome (MERS) 
• Ebola update 
• Anthrax transfer update 
• Meeting announcements and training opportunities 
 
1914 Typhoid Fever outbreak in Adel, Iowa 
The investigation of a 1914 Typhoid Fever (TF) outbreak in Adel, Iowa sheds light on 
the public health food and waterborne disease standards of the early 20th century.  On 
November 5, 1914, a social held by the Ladies Aid Society resulted in a large number of 
the attendees becoming ill with TF. Servers, kitchen staff, and the water used all tested 
negative for typhoid bacteria. An investigation determined the chicken sandwiches 
served at the event were prepared using cream and broth from the chicken, with very 
little cooking. The cream was from previous day’s milking, which had been stored in the 
“cool” basement of the farm home, then brought to town and kept cool until two hours 
before it was used. 
 
The farm that was the source of the milk was adjacent to a mill slough in Adel, where 
several hundred fishermen would come on a yearly basis to camp and fish. 
Investigators believe mill slough and the limited area for human waste near the farm 
made it possible for infection to accumulate in the barnyard area and soil, thus causing 
possible spread to nearby cows and their milk. In turn, investigators determined this to 
be a very viable source of the TF outbreak. For more on this outbreak, visit the IPHA’s 
summer newsletter at www.iowapha.org/Resources/Documents/PHM-
Summer%202015.pdf.  
 
Updated sexually transmitted disease treatment guidelines 
CDC recently updated its guidelines for the treatment of persons who have or are at risk 
for sexually transmitted diseases (STDs). The updated guidelines discuss: 
1. Alternative treatment regimens for Neisseria gonorrhoeae;  
2. The use of nucleic acid amplification tests for the diagnosis of trichomoniasis;  
3. Alternative treatment options for genital warts;  
4. The role of Mycoplasma genitalium in urethritis/cervicitis and treatment-related 
implications;  
5. Updated HPV vaccine recommendations and counseling messages;  
6. The management of persons who are transgender;  
7. Annual testing for hepatitis C in persons with HIV infection;  
8. Updated recommendations for diagnostic evaluation of urethritis; and  
9. Re-testing to detect repeat infection. Physicians and other health care providers 
can use these guidelines to assist in the prevention and treatment of STDs. 
For more information, visit 
www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm?s_cid=rr6403a1_e. 
 
Middle East Respiratory Syndrome (MERS) 
On May 20, the Republic of Korea reported its first laboratory confirmed case of Middle 
Eastern Respiratory Syndrome (MERS).  By June 5, 36 cases had been confirmed by 
the World Health Organization, all linked to health care facilities with confirmed MERS 
cases.  
 
Due to this outbreak in Korea, health care providers in Iowa should be alert for patients 
who develop severe acute lower respiratory illness (e.g., requiring hospitalization) and 
visited a health care facility in the Republic of Korea within 14 days before illness onset. 
For more information, visit wwwnc.cdc.gov/travel/notices/watch/mers-republic-of-korea. 
 
Ebola update  
CDC has not changed the recommendations concerning the screening of patients, nor 
surveillance of travelers coming from Liberia. For more information on the current Ebola 
situation in Africa, visit www.cdc.gov/vhf/ebola/. 
 
Anthrax transfer update 
CDC is investigating the unintentional transfer of anthrax from the U.S. Department of 
Defense (DOD) to labs in multiple states and overseas. As of June 8, 66 laboratories in 
19 states and Washington D.C., as well as three foreign countries are now known to 
have received the live anthrax samples. An investigation is ongoing. No Iowa 
laboratories have been identified as having received these anthrax samples. 
 
CDC is investigating with DOD and other federal and state partners to identify all the 
labs that received these samples by determining if these labs also received other live 
samples, epidemiologic consultation, worker safety review, laboratory analysis, and 
handling of laboratory waste. All samples involved in the investigation are being 
securely transferred to CDC or Laboratory Response Network laboratories for further 
testing. The risk to the general public is very low. For more information on anthrax, visit 
www.cdc.gov/anthrax/.  
 
Meeting announcements and training opportunities 
None 
 
Have a healthy and happy week! 
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